UBS Oconnor LLC
- SEC CIK
- 0001132716
- Latest filing
- Aug 14, 2026
UBX holding history
Unity Biotechnology, Inc. in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
UBX overviewAll 13F holders of UBXFull Q4 2025 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −79,354−100.0% | Sold out | Holders |
| Q3 2024 | 79,354 | $116.7K | <0.1% | +7,371+10.2% | Added | Holders |
| Q2 2024 | 71,983 | $97.2K | <0.1% | +1,586+2.3% | Added | Holders |
| Q1 2024 | 70,397 | $115.5K | <0.1% | −22,303−24.1% | Reduced | Holders |
| Q4 2023 | 92,700 | $178.9K | <0.1% | −86,380−48.2% | Reduced | Holders |
| Q3 2023 | 179,080 | $429.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 179,080 | $456.7K | <0.1% | −33,960−15.9% | Reduced | Holders |
| Q1 2023 | 213,040 | $347.3K | <0.1% | +213,040 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −60,650−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q3 2022 | 606,500 | $240.0K | <0.1% | +606,500 | New | Holders |